{"entity":{"type":"insider","cik":"0001539937","url":"/insider/0001539937","json_url":"/insider/0001539937.json","name":"Khattar Jack A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":35,"first":"2012-05-07","last":"2026-03-16","span_basis":"filed_date"},"name_variants":[{"name":"Khattar Jack A.","source":"filing","n_filings":35,"first_seen":"2012-05-07","last_seen":"2026-03-16"}],"transactions":[{"id":5961568,"accession":"0001539937-26-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001539937-26-000008","line_url":"/filing/0001539937-26-000008","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":50.374983428571426,"price_display":"50.37","price_state":"stated","total_value":1763124.42,"total_display":"1,763,124.42","total_whole":"1,763,124","shares_owned_after":968962.0,"shares_owned_after_display":"968,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-16","scope":"insider","n_lines":3},{"id":5112575,"accession":"0001628280-25-044830","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-044830","line_url":"/filing/0001628280-25-044830","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59900.0,"shares_display":"59,900","price_per_share":50.5732285475793,"price_display":"50.57","price_state":"stated","total_value":3029336.39,"total_display":"3,029,336.39","total_whole":"3,029,336","shares_owned_after":1208107.0,"shares_owned_after_display":"1,208,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-10","scope":"insider","n_lines":2},{"id":4820536,"accession":"0001539937-25-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000028","line_url":"/filing/0001539937-25-000028#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1904.0,"shares_display":"1,904","price_per_share":48.06,"price_display":"48.06","price_state":"stated","total_value":91506.24,"total_display":"91,506.24","total_whole":"91,506","shares_owned_after":1161233.0,"shares_owned_after_display":"1,161,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4218932,"accession":"0001539937-25-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000026","line_url":"/filing/0001539937-25-000026#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40173.0,"shares_display":"40,173","price_per_share":48.07,"price_display":"48.07","price_state":"stated","total_value":1931116.11,"total_display":"1,931,116.11","total_whole":"1,931,116","shares_owned_after":1160870.0,"shares_owned_after_display":"1,160,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-02","scope":"insider"},{"id":4364258,"accession":"0001539937-25-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000024","line_url":"/filing/0001539937-25-000024#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8588.0,"shares_display":"8,588","price_per_share":48.25,"price_display":"48.25","price_state":"stated","total_value":414371.0,"total_display":"414,371.00","total_whole":"414,371","shares_owned_after":1147258.0,"shares_owned_after_display":"1,147,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4472723,"accession":"0001539937-25-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000022","line_url":"/filing/0001539937-25-000022#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10235.0,"shares_display":"10,235","price_per_share":48.02,"price_display":"48.02","price_state":"stated","total_value":491484.7,"total_display":"491,484.70","total_whole":"491,485","shares_owned_after":1144336.0,"shares_owned_after_display":"1,144,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-09-30","scope":"insider"},{"id":4442565,"accession":"0001539937-25-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000020","line_url":"/filing/0001539937-25-000020#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29513.0,"shares_display":"29,513","price_per_share":47.23,"price_display":"47.23","price_state":"stated","total_value":1393898.99,"total_display":"1,393,898.99","total_whole":"1,393,899","shares_owned_after":1140883.0,"shares_owned_after_display":"1,140,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-23","filed_date":"2025-09-24","scope":"insider"},{"id":5169129,"accession":"0001539937-25-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000018","line_url":"/filing/0001539937-25-000018#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16587.0,"shares_display":"16,587","price_per_share":47.02,"price_display":"47.02","price_state":"stated","total_value":779920.74,"total_display":"779,920.74","total_whole":"779,921","shares_owned_after":1122456.0,"shares_owned_after_display":"1,122,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-23","scope":"insider"},{"id":4926478,"accession":"0001539937-25-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000014","line_url":"/filing/0001539937-25-000014#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6322.0,"shares_display":"6,322","price_per_share":46.29,"price_display":"46.29","price_state":"stated","total_value":292645.38,"total_display":"292,645.38","total_whole":"292,645","shares_owned_after":1111983.0,"shares_owned_after_display":"1,111,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":4472712,"accession":"0001539937-25-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000012","line_url":"/filing/0001539937-25-000012#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55578.0,"shares_display":"55,578","price_per_share":46.01,"price_display":"46.01","price_state":"stated","total_value":2557143.78,"total_display":"2,557,143.78","total_whole":"2,557,144","shares_owned_after":1110231.0,"shares_owned_after_display":"1,110,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":5091446,"accession":"0001539937-25-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001539937-25-000010","line_url":"/filing/0001539937-25-000010#line-4","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24150.0,"shares_display":"24,150","price_per_share":45.12,"price_display":"45.12","price_state":"stated","total_value":1089648.0,"total_display":"1,089,648.00","total_whole":"1,089,648","shares_owned_after":1092633.0,"shares_owned_after_display":"1,092,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-08-29","scope":"insider"},{"id":5091436,"accession":"0001539937-25-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000010","line_url":"/filing/0001539937-25-000010#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10650.0,"shares_display":"10,650","price_per_share":45.05,"price_display":"45.05","price_state":"stated","total_value":479782.5,"total_display":"479,782.50","total_whole":"479,783","shares_owned_after":1078004.0,"shares_owned_after_display":"1,078,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-29","scope":"insider"},{"id":4820528,"accession":"0001539937-25-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000008","line_url":"/filing/0001539937-25-000008#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":1071459.0,"shares_owned_after_display":"1,071,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-27","scope":"insider"},{"id":4783794,"accession":"0001539937-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001539937-25-000006","line_url":"/filing/0001539937-25-000006#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":67500.0,"total_display":"67,500.00","total_whole":"67,500","shares_owned_after":1070848.0,"shares_owned_after_display":"1,070,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":5174032,"accession":"0001628280-25-039302","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-25-039302","line_url":"/filing/0001628280-25-039302","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140000.0,"shares_display":"140,000","price_per_share":42.024,"price_display":"42.02","price_state":"stated","total_value":5883360.0,"total_display":"5,883,360.00","total_whole":"5,883,360","shares_owned_after":1069933.0,"shares_owned_after_display":"1,069,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-08","scope":"insider","n_lines":3},{"id":2225797,"accession":"0001628280-24-047142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-047142","line_url":"/filing/0001628280-24-047142#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":36.29,"price_display":"36.29","price_state":"stated","total_value":4536250.0,"total_display":"4,536,250.00","total_whole":"4,536,250","shares_owned_after":926172.0,"shares_owned_after_display":"926,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":3187443,"accession":"0001628280-24-046663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-046663","line_url":"/filing/0001628280-24-046663#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":36.68,"price_display":"36.68","price_state":"stated","total_value":4585000.0,"total_display":"4,585,000.00","total_whole":"4,585,000","shares_owned_after":926172.0,"shares_owned_after_display":"926,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-08","scope":"insider"},{"id":8472626,"accession":"0001104659-23-011255","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-011255","line_url":"/filing/0001104659-23-011255#line-4","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":42.02,"price_display":"42.02","price_state":"stated","total_value":8404.0,"total_display":"8,404.00","total_whole":"8,404","shares_owned_after":804272.0,"shares_owned_after_display":"804,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-06","scope":"insider"},{"id":8472618,"accession":"0001104659-23-011255","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-011255","line_url":"/filing/0001104659-23-011255#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13532.0,"shares_display":"13,532","price_per_share":42.055,"price_display":"42.06","price_state":"stated","total_value":569088.26,"total_display":"569,088.26","total_whole":"569,088","shares_owned_after":804142.0,"shares_owned_after_display":"804,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-06","scope":"insider"},{"id":8318716,"accession":"0001104659-23-010575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-010575","line_url":"/filing/0001104659-23-010575#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":42.0067,"price_display":"42.01","price_state":"stated","total_value":12602.01,"total_display":"12,602.01","total_whole":"12,602","shares_owned_after":795159.0,"shares_owned_after_display":"795,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":7891012,"accession":"0001104659-23-009959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-009959","line_url":"/filing/0001104659-23-009959#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":976.0,"shares_display":"976","price_per_share":42.0106,"price_display":"42.01","price_state":"stated","total_value":41002.3456,"total_display":"41,002.35","total_whole":"41,002","shares_owned_after":794961.0,"shares_owned_after_display":"794,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":8673196,"accession":"0001104659-23-005449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-005449","line_url":"/filing/0001104659-23-005449#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4936.0,"shares_display":"4,936","price_per_share":40.3959,"price_display":"40.40","price_state":"stated","total_value":199394.1624,"total_display":"199,394.16","total_whole":"199,394","shares_owned_after":794317.0,"shares_owned_after_display":"794,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider"},{"id":7890999,"accession":"0001104659-23-005057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-005057","line_url":"/filing/0001104659-23-005057#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25446.0,"shares_display":"25,446","price_per_share":40.0349,"price_display":"40.03","price_state":"stated","total_value":1018728.0654,"total_display":"1,018,728.07","total_whole":"1,018,728","shares_owned_after":791173.0,"shares_owned_after_display":"791,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6307888,"accession":"0001104659-22-129580","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-22-129580","line_url":"/filing/0001104659-22-129580#line-5","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11354.0,"shares_display":"11,354","price_per_share":38.1425,"price_display":"38.14","price_state":"stated","total_value":433069.945,"total_display":"433,069.94","total_whole":"433,070","shares_owned_after":814699.0,"shares_owned_after_display":"814,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":6307882,"accession":"0001104659-22-129580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-129580","line_url":"/filing/0001104659-22-129580#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4006.0,"shares_display":"4,006","price_per_share":38.0222,"price_display":"38.02","price_state":"stated","total_value":152316.9332,"total_display":"152,316.93","total_whole":"152,317","shares_owned_after":791956.0,"shares_owned_after_display":"791,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-22","scope":"insider"},{"id":6247941,"accession":"0001104659-22-122479","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-122479","line_url":"/filing/0001104659-22-122479#line-4","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11135.0,"shares_display":"11,135","price_per_share":35.176,"price_display":"35.18","price_state":"stated","total_value":391684.76,"total_display":"391,684.76","total_whole":"391,685","shares_owned_after":789434.0,"shares_owned_after_display":"789,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-11-28","scope":"insider"},{"id":6247935,"accession":"0001104659-22-122479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-122479","line_url":"/filing/0001104659-22-122479#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2259.0,"shares_display":"2,259","price_per_share":35.0548,"price_display":"35.05","price_state":"stated","total_value":79188.7932,"total_display":"79,188.79","total_whole":"79,189","shares_owned_after":782775.0,"shares_owned_after_display":"782,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-28","scope":"insider"},{"id":6746014,"accession":"0001104659-22-121796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-121796","line_url":"/filing/0001104659-22-121796#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":35.0018,"price_display":"35.00","price_state":"stated","total_value":21001.08,"total_display":"21,001.08","total_whole":"21,001","shares_owned_after":781418.0,"shares_owned_after_display":"781,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6150964,"accession":"0001104659-22-121285","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-121285","line_url":"/filing/0001104659-22-121285#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531.0,"shares_display":"531","price_per_share":35.0136,"price_display":"35.01","price_state":"stated","total_value":18592.2216,"total_display":"18,592.22","total_whole":"18,592","shares_owned_after":781059.0,"shares_owned_after_display":"781,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider"},{"id":6520465,"accession":"0001104659-22-119930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-119930","line_url":"/filing/0001104659-22-119930#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1115.0,"shares_display":"1,115","price_per_share":35.0027,"price_display":"35.00","price_state":"stated","total_value":39028.0105,"total_display":"39,028.01","total_whole":"39,028","shares_owned_after":780742.0,"shares_owned_after_display":"780,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6110043,"accession":"0001104659-22-092614","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-092614","line_url":"/filing/0001104659-22-092614#line-3","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14690.0,"shares_display":"14,690","price_per_share":34.013,"price_display":"34.01","price_state":"stated","total_value":499650.97,"total_display":"499,650.97","total_whole":"499,651","shares_owned_after":775559.0,"shares_owned_after_display":"775,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6476401,"accession":"0001104659-22-092204","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-092204","line_url":"/filing/0001104659-22-092204#line-3","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17302.0,"shares_display":"17,302","price_per_share":34.028,"price_display":"34.03","price_state":"stated","total_value":588752.456,"total_display":"588,752.46","total_whole":"588,752","shares_owned_after":759901.0,"shares_owned_after_display":"759,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6745664,"accession":"0001104659-22-089438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-089438","line_url":"/filing/0001104659-22-089438#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28437.0,"shares_display":"28,437","price_per_share":31.22,"price_display":"31.22","price_state":"stated","total_value":887803.14,"total_display":"887,803.14","total_whole":"887,803","shares_owned_after":741441.0,"shares_owned_after_display":"741,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-11","scope":"insider"},{"id":6636631,"accession":"0001104659-22-088700","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-088700","line_url":"/filing/0001104659-22-088700#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39431.0,"shares_display":"39,431","price_per_share":31.15,"price_display":"31.15","price_state":"stated","total_value":1228275.65,"total_display":"1,228,275.65","total_whole":"1,228,276","shares_owned_after":724978.0,"shares_owned_after_display":"724,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-10","scope":"insider"},{"id":6718422,"accession":"0001104659-22-088044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-088044","line_url":"/filing/0001104659-22-088044","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117907.0,"shares_display":"117,907","price_per_share":31.460409644889616,"price_display":"31.46","price_state":"stated","total_value":3709402.52,"total_display":"3,709,402.52","total_whole":"3,709,403","shares_owned_after":711341.0,"shares_owned_after_display":"711,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider","n_lines":2},{"id":5195006,"accession":"0000899243-21-046980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-046980","line_url":"/filing/0000899243-21-046980#line-1","is_derivative":false,"issuer_cik":"0001539937","issuer_name":"scPharmaceuticals Inc.","issuer_ticker":"SCPH","issuer_name_source":null,"issuer_url":"/issuer/0001539937","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.9138,"price_display":"3.91","price_state":"stated","total_value":19569.0,"total_display":"19,569.00","total_whole":"19,569","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-06","scope":"insider"},{"id":7995673,"accession":"0001104659-19-047536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047536","line_url":"/filing/0001104659-19-047536#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7200.0,"shares_display":"7,200","price_per_share":26.3864,"price_display":"26.39","price_state":"stated","total_value":189982.08,"total_display":"189,982.08","total_whole":"189,982","shares_owned_after":465141.0,"shares_owned_after_display":"465,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-27","scope":"insider"},{"id":5466735,"accession":"0001181431-13-017867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-017867","line_url":"/filing/0001181431-13-017867#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.1461,"price_display":"6.15","price_state":"stated","total_value":61461.0,"total_display":"61,461.00","total_whole":"61,461","shares_owned_after":412058.0,"shares_owned_after_display":"412,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-19","scope":"insider"},{"id":2146975,"accession":"0001179110-12-007833","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-007833","line_url":"/filing/0001179110-12-007833#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001539937","owner_name":"Khattar Jack A.","owner_display_name":"Khattar Jack A.","owner_url":"/insider/0001539937","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":402058.0,"shares_owned_after_display":"402,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-04","filed_date":"2012-05-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356576","name":"SUPERNUS PHARMACEUTICALS, INC.","url":"/issuer/0001356576","role":"Director, Officer (President, CEO)","n_filings":34,"first_seen":"2012-05-07","last_seen":"2026-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001604950","name":"scPharmaceuticals Inc.","url":"/issuer/0001604950","role":"Director","n_filings":1,"first_seen":"2021-12-06","last_seen":"2021-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001539937","retrieved_at":"2026-08-27T01:46:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}